Diabetes technology

The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy

Diabetes Res Clin PractPublished Cross-sectional study

Authors' conclusion

The ACI could represent a useful and easy-to-assess metric for AHCL-treated individuals with T1D. In our cohort an ACI < 30 % was associated to better glucose control and variability.

Study context

Population
Adult and pediatric patients with T1D using different advanced hybrid closed loop (AHCL) systems87 adult, 37 pediatric
Participants
124 participants
Exposure
ACI <30% vs ACI ≥30%
Outcome
Correlation of AHCL parameters (TDD, total daily basal (TDBa), TDBo, ACI) with HbA1c and sensor-derived metrics
Methodological detailsretrospective
  • Retrospective

Main finding

As reported in the abstract

Association of ACI with HbA1c, TAR and TIR
ACI the only AHCL-derived parameter directly associated with HbA1c
p = 0.03
ACI directly associated with TAR 180-250 mg/dL (10-13.9 mmol/L)
p < 0.01
ACI inversely correlated with TIR 70-180 mg/dL (3.9-10 mmol/L)
p < 0.01

Observational data: associations, not effects.

Further findings

HbA1c by ACI category · reduced HbA1c with ACI < 30 %

P = 0.02

OutcomeOR (CI)P value
TIR > 70 %3.18 (1.19–8.46)P = 0.02
CV < 36 %2.86 (1.07–8.27)P = 0.03

Original publication

The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy. Diabetes Res Clin Pract. Published 10 April 2025. doi:10.1016/j.diabres.2025.112173

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.